全文获取类型
收费全文 | 2726篇 |
免费 | 221篇 |
国内免费 | 25篇 |
专业分类
耳鼻咽喉 | 18篇 |
儿科学 | 132篇 |
妇产科学 | 71篇 |
基础医学 | 333篇 |
口腔科学 | 50篇 |
临床医学 | 375篇 |
内科学 | 614篇 |
皮肤病学 | 50篇 |
神经病学 | 154篇 |
特种医学 | 298篇 |
外科学 | 254篇 |
综合类 | 61篇 |
预防医学 | 200篇 |
眼科学 | 21篇 |
药学 | 175篇 |
中国医学 | 21篇 |
肿瘤学 | 145篇 |
出版年
2023年 | 31篇 |
2022年 | 22篇 |
2021年 | 53篇 |
2020年 | 32篇 |
2019年 | 47篇 |
2018年 | 89篇 |
2017年 | 57篇 |
2016年 | 69篇 |
2015年 | 72篇 |
2014年 | 109篇 |
2013年 | 127篇 |
2012年 | 139篇 |
2011年 | 124篇 |
2010年 | 116篇 |
2009年 | 112篇 |
2008年 | 117篇 |
2007年 | 89篇 |
2006年 | 114篇 |
2005年 | 108篇 |
2004年 | 85篇 |
2003年 | 83篇 |
2002年 | 64篇 |
2001年 | 61篇 |
2000年 | 48篇 |
1999年 | 53篇 |
1998年 | 61篇 |
1997年 | 62篇 |
1996年 | 82篇 |
1995年 | 59篇 |
1994年 | 50篇 |
1993年 | 57篇 |
1992年 | 45篇 |
1991年 | 41篇 |
1990年 | 34篇 |
1989年 | 53篇 |
1988年 | 43篇 |
1987年 | 49篇 |
1986年 | 43篇 |
1985年 | 40篇 |
1984年 | 27篇 |
1983年 | 17篇 |
1982年 | 26篇 |
1981年 | 15篇 |
1980年 | 11篇 |
1978年 | 9篇 |
1977年 | 20篇 |
1976年 | 17篇 |
1975年 | 19篇 |
1974年 | 10篇 |
1973年 | 9篇 |
排序方式: 共有2972条查询结果,搜索用时 31 毫秒
1.
2.
ME BURGE AM JOSHUA CM McNEIL R HUI MJ BOYER R ABRAHAM 《Asia-Pacific Journal of Clinical Oncology》2005,1(1):47-52
Background: Pemetrexed and cisplatin have recently been shown to significantly improve survival compared with cisplatin alone. However, there are only limited data reflecting teaching hospital experience outside a clinical trial. Pemetrexed has only been available in Australia on a restricted basis since 2002. We reviewed our experience of patients treated on the Australian ‘Special Access Scheme’ at three major thoracic oncology units. Methods: Charts were reviewed for all patients enrolled on the scheme. Data was extracted on age, World Health Organization (WHO) performance status, histology, prior therapy, time from diagnosis to starting pemetrexed, chemotherapy (pemetrexed alone or with a platinum), cycle number, response rate, actuarial progression‐free and overall survival. Doses were cisplatin 75 mg/m2 or carboplatin AUC = 5 and pemetrexed 500 mg/m2 every 21 days. Results: 52 patients (32 male and 20 female) were reviewed. Median age was 58 years and 88% were WHO 0–1. Histology included 54% epithelial, 17% biphasic (epithelial and sarcomatoid) and 21% undefined. The median time from diagnosis to administration of pemetrexed was 145 days. Sixty‐five percent had minimal surgical intervention with video assisted thoracoscopy, pleurodesis and biopsy, while 19% had received prior palliative radiation. Seventy‐one percent were chemotherapy naïve, the remaining 29% having received previous platinum and/or gemcitabine regimens. Twenty‐three percent had pemetrexed alone, 35% in combination with carboplatin and 42% with cisplatin. The median number of cycles was 4 (range 1–13). The response rate was 33%. No toxicity was observed in 20% grade 3–4 toxicity in 10% (majority nausea/vomiting). The median progression‐free and overall survival times from starting pemetrexed were 184 days and 298 days, respectively. Conclusions: Pemetrexed‐based regimens are safe and effective in a community setting in malignant mesothelioma. 相似文献
3.
A case-referent study of lung cancer, occupational exposures and smoking. II. Role of asbestos exposure 总被引:6,自引:0,他引:6
H Kjuus R Skjaerven S Lang?rd J T Lien T Aamodt 《Scandinavian journal of work, environment & health》1986,12(3):203-209
In a hospital-based case-referent study of 176 incident lung cancer cases, ascertained during a five-year period from two county hospitals, the role of asbestos exposure and smoking has been studied. Information on asbestos exposure was obtained from personal interviews, and allocated to four exposure categories, according to the intensity and duration of the exposure. Twenty-five percent of the cases and 10% of the referents had been moderately to heavily exposed to asbestos during their working career. A statistically significant trend in risk ratio related to the degree of exposure was observed, with a more than fourfold risk among the heavily exposed. The strongest association was found between asbestos exposure and small cell carcinoma, and the weakest association between asbestos exposure and adenocarcinoma. Very high risk ratios were observed among asbestos-exposed subjects who were heavy smokers, and the interaction observed between asbestos and smoking conformed more closely to a multiplicative model than to an additive one. The results suggest that the observed association between lung cancer and occupational exposures in this study was, to a large extent, due to asbestos exposure. Information on such exposure was missing in 90% of the medical records of these patients. 相似文献
4.
5.
6.
7.
8.
I A Cliffe E L Lien H L Mansell K E Steiner R S Todd A C White R M Black 《Journal of medicinal chemistry》1992,35(7):1169-1175
A series of pyrimido[1,2-a]indoles were synthesized and studied for their hypoglycemic activity following oral administration at a standard dose of 100 mg/kg to fed rats. The effect of 10-alkoxyalkyl, 10-alkyl, 10-aryl, and 3,3-dialkyl substitution on the activity of 10-hydroxypyrimido[1,2-a]indoles was investigated. Relative potencies of a number of the most active compounds were defined by three-point dose-response studies. The most potent compounds were those with either 3,3-dimethyl substituents, compounds 21, 22, and 38, or 3,3-spirocyclohexane substituents, compounds 39 and 49. 10-Aminopyrimido[1,2-a]indoles were in general less active than the 10-hydroxy analogues, and potency was further decreased by derivatizing the 10-amino group. The most potent 10-amino derivatives were 57 and 58. 相似文献
9.